Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
Conditions
Premenstrual Dysphoric Disorder
What is the purpose of this trial?
This study will evaluate the effectiveness of sertraline in reducing symptoms in women diagnosed with premenstrual dysphoric disorder.
Participation Guidelines
- Age:
- 18 Years - 48 Years
- Gender:
- Female
Click here for detailed information about who can participate in this trial.
- Sponsor:
- National Institute of Mental Health (NIMH)
Weill Medical College of Cornell University - Dates:
- September 2007
- Last Updated:
- June 27, 2012
- Study HIC#:
- 0108012595
Clinicaltrials.gov ID: NCT00536198
